Lakeside Holding (LSH) Registration Filing summary

Offering details and pricing

• 1,250,000 shares of common stock are being offered, with an over-allotment option for up to 187,500 additional shares (15% of the base offering).

• Shares are to be offered at a public price to be determined, with underwriters purchasing at 93% of the offering price (94% for company-introduced investors).

• The offering is underwritten by The Benchmark Company, LLC and Axiom Capital Management, Inc., with a right of first refusal for future transactions for 12 months.

• Representatives' warrants equal to 5% of the public securities are issued to the underwriters, exercisable 180 days after closing for five years at the IPO price.

• The shares are approved for listing on Nasdaq Capital Market under the symbol "LSH."

Use of proceeds and capital allocation

• Net proceeds will be applied as described in the "Use of Proceeds" section of the registration statement, with a commitment to use funds in line with the prospectus.

• None of the net proceeds will be paid to participating FINRA members or affiliates, except as specifically authorized.

Underwriters and syndicate

• The Benchmark Company, LLC and Axiom Capital Management, Inc. are the lead underwriters.

• Underwriters receive a non-accountable expense allowance of 1% of gross proceeds and reimbursement for accountable out-of-pocket expenses up to $175,000.

• Representatives' warrants are subject to FINRA Rule 5110 transfer restrictions for 180 days post-offering.